AAD 2025 Significant Improvement in Psoriasis Seen With Oral Drug Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear skin ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

For Anthony, her plaque psoriasis has remained relatively the same since her diagnosis 10 years ago. "I haven't seen it get worse. I haven't seen it get better.

ORLANDO, Fla. — Adults with moderate to severe plaque psoriasis taking the novel oral drug icotrokinra had significant improvement starting at week 16, with increased response rates continuing ...

While nearly 8 million Americans live with plaque psoriasis, its impact is often unseen or covered up. 1 Art, whose music has touched millions worldwide, lived silently with his psoriasis—until now.

(RTTNews) - Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO ...